| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Apr 20, 2026 |
Biogen Inc
BIIB
|
BUY |
$250.00
Est. +41%
|
$177.35 | $205.97 |
Pending
|
$198.64
+12.0%
|
| Mar 12, 2026 |
Merck & Co Inc
MRK
|
BUY |
$150.00
Est. +29%
|
$116.22 | $124.00 |
Pending
|
$114.90
-1.1%
|
| Feb 11, 2026 |
Gilead Sciences, Inc.
GILD
|
BUY |
$165.00
Est. +12%
|
$147.23 | $157.27 |
Pending
|
$124.30
-15.6%
|
| Feb 06, 2026 |
Bristol-Myers Squibb Co.
BMY
|
BUY |
$60.00
Est. +1%
|
$59.52 | $62.89 |
Target Met
|
$56.24
-5.5%
|
| Feb 05, 2026 |
Lilly(Eli) & Co
LLY
|
BUY |
$1,280.00
Est. +16%
|
$1,107.12 | $1,182.73 |
Pending
|
$1,129.59
+2.0%
|
| Dec 16, 2025 |
Milestone Pharmaceuticals Inc
MIST
|
BUY |
$8.00
Est. +242%
|
$2.34 | $2.57 |
Pending
|
$1.31
-44.0%
|
| Nov 20, 2025 |
Regeneron Pharmaceuticals, Inc.
REGN
|
SELL |
$700.00
Est. +0%
|
$702.75 | $591.52 (Low) |
Target Met
|
$614.65
+12.5%
|
| Oct 28, 2025 |
Biomarin Pharmaceutical Inc. - Registered Shares
BMRN
|
BUY |
$70.00
Est. +27%
|
$55.06 | $66.28 |
Pending
|
$55.65
+1.1%
|
| Aug 05, 2025 |
BioNTech SE - ADR
BNTX
|
BUY |
$150.00
Est. +35%
|
$111.07 | $124.00 |
Pending
|
$90.80
-18.2%
|
| Aug 01, 2025 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$580.00
Est. +3%
|
$563.43 | $821.11 |
Target Met
|
$614.65
+9.1%
|
| Feb 12, 2025 |
Biogen Inc
BIIB
|
BUY |
$165.00
Est. +24%
|
$133.43 | $202.41 |
Target Met
|
$198.64
+48.9%
|
| Jan 31, 2025 |
Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A
IRWD
|
BUY |
$7.00
Est. +199%
|
$2.34 | $5.78 |
Miss
|
$3.69
+57.7%
|
| Jan 30, 2025 |
Vertex Pharmaceuticals, Inc.
VRTX
|
BUY |
$460.00
Est. +4%
|
$441.52 | $519.68 |
Target Met
|
$450.69
+2.1%
|
| Oct 23, 2024 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$1,050.00
Est. +9%
|
$962.34 | $959.60 |
Miss
|
$614.65
-36.1%
|
| Oct 21, 2024 |
Travere Therapeutics Inc
TVTX
|
BUY |
$27.00
Est. +51%
|
$17.87 | $28.69 |
Target Met
|
$53.80
+201.1%
|
| Aug 09, 2024 |
Lilly(Eli) & Co
LLY
|
BUY |
$1,000.00
Est. +18%
|
$845.31 | $972.53 |
Precision Hit (±3%)
|
$1,129.59
+33.6%
|
| Aug 09, 2024 |
Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A
IRWD
|
BUY |
$12.00
Est. +196%
|
$4.05 | $5.21 |
Miss
|
$3.69
-8.9%
|
| Aug 07, 2024 |
AMGEN Inc.
AMGN
|
BUY |
$335.00
Est. +2%
|
$328.95 | $339.17 |
Precision Hit (±3%)
|
$350.53
+6.6%
|
| Jul 31, 2024 |
Pfizer Inc.
PFE
|
SELL |
$30.00
Est. +4%
|
$31.39 | $20.92 (Low) |
Target Met
|
$26.00
+17.2%
|
| Jun 27, 2024 |
Biomarin Pharmaceutical Inc. - Registered Shares
BMRN
|
BUY |
$115.00
Est. +35%
|
$85.25 | $94.85 |
Miss
|
$55.65
-34.7%
|
| Jun 12, 2024 |
Merck & Co Inc
MRK
|
BUY |
$140.00
Est. +7%
|
$131.05 | $129.93 |
Miss
|
$114.90
-12.3%
|
| Jun 07, 2024 |
Halozyme Therapeutics Inc.
HALO
|
BUY |
$58.00
Est. +13%
|
$51.44 | $70.51 |
Target Met
|
$71.28
+38.6%
|
| May 22, 2024 |
Ironwood Pharmaceuticals Inc - Ordinary Shares - Class A
IRWD
|
BUY |
$14.00
Est. +106%
|
$6.78 | $7.11 |
Miss
|
$3.69
-45.6%
|
| May 16, 2024 |
Lilly(Eli) & Co
LLY
|
BUY |
$875.00
Est. +13%
|
$771.12 | $972.53 |
Target Met
|
$1,129.59
+46.5%
|
| Apr 23, 2024 |
Neurocrine Biosciences, Inc.
NBIX
|
BUY |
$170.00
Est. +22%
|
$139.35 | $157.98 |
Miss
|
$159.51
+14.5%
|
| Apr 17, 2024 |
AMGEN Inc.
AMGN
|
BUY |
$320.00
Est. +21%
|
$265.11 | $346.85 |
Target Met
|
$350.53
+32.2%
|
| Mar 27, 2024 |
Merck & Co Inc
MRK
|
BUY |
$135.00
Est. +4%
|
$130.19 | $129.93 |
Miss
|
$114.90
-11.7%
|
| Apr 12, 2023 |
AMGEN Inc.
AMGN
|
BUY |
$265.00
Est. +6%
|
$251.08 | - | - |
$350.53
+39.6%
|
| Mar 10, 2023 |
AMGEN Inc.
AMGN
|
BUY |
$275.00
Est. +20%
|
$228.84 | - | - |
$350.53
+53.2%
|
| Jun 11, 2022 |
Regeneron Pharmaceuticals, Inc.
REGN
|
BUY |
$735.00
Est. +29%
|
$571.81 | - | - |
$614.65
+7.5%
|
| May 18, 2022 |
Bristol-Myers Squibb Co.
BMY
|
SELL |
$70.00
Est. +11%
|
$78.22 | - | - |
$56.24
+28.1%
|
| May 10, 2022 |
Pfizer Inc.
PFE
|
BUY |
$141.39
Est. +185%
|
$49.64 | - | - |
$26.00
-47.6%
|
| May 09, 2022 |
Pfizer Inc.
PFE
|
BUY |
$55.00
Est. +12%
|
$49.04 | - | - |
$26.00
-47.0%
|
| Apr 30, 2022 |
Lilly(Eli) & Co
LLY
|
BUY |
$305.00
Est. +4%
|
$292.13 | - | - |
$1,129.59
+286.7%
|
| Apr 18, 2022 |
Biogen Inc
BIIB
|
BUY |
$265.00
Est. +25%
|
$212.55 | - | - |
$198.64
-6.5%
|
| Mar 31, 2022 |
Gilead Sciences, Inc.
GILD
|
BUY |
$63.00
Est. +6%
|
$59.45 | - | - |
$124.30
+109.1%
|
| Feb 04, 2022 |
Biogen Inc
BIIB
|
BUY |
$235.00
Est. +6%
|
$221.53 | - | - |
$198.64
-10.3%
|
| Jan 04, 2022 |
Lilly(Eli) & Co
LLY
|
BUY |
$280.00
Est. +5%
|
$265.70 | - | - |
$1,129.59
+325.1%
|
| Dec 08, 2021 |
Abbvie Inc
ABBV
|
BUY |
$165.00
Est. +37%
|
$120.62 | - | - |
$221.59
+83.7%
|